Cimpress plc logo CMPR - Cimpress plc

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 2
HOLD 7
SELL 0
STRONG
SELL
0
| PRICE TARGET: $115.50 DETAILS
HIGH: $121.00
LOW: $110.00
MEDIAN: $115.50
CONSENSUS: $115.50
UPSIDE: 32.38%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 50% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Moderate
Trading 29.3% above fair value
Current Price $87.25
Bear Case $43.73 49.9% downside ($43.73 - $87.25) / $87.25 = -49.9% 4% stage 1 growth, 12% discount
Fair Value $67.50 22.6% downside ($67.50 - $87.25) / $87.25 = -22.6% 7% stage 1 growth, 12% discount
Bull Case $89.07 2.1% upside ($89.07 - $87.25) / $87.25 = 2.1% 9% stage 1 growth, 12% discount

Adjust Assumptions

7.1%
12.0%
3.0%

Key Value Driver

FCF growth rate (7% base case)

Terminal Value % of EV 32%
Implied Market Multiple 17.7x
Market is pricing in (growth) 9.1% vs our 7.1% base

Plain-Language Summary

Using a two-stage FCF DCF with 7% growth decelerating over 15 years, discounted at 12%, the base-case intrinsic value is $67.50 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (9 analysts) $115.50
Analyst Range $110.00 – $121.00
Divergence from AlphaVal 42%

Warnings

Stock-based employee pay equals 64% of profits. This dilutes existing shareholders, so cash flow alone overstates what owners really earn.
Wall Street's average price target is $115.50 (from 9 analysts). Our estimate is 42% below the consensus -- consider that gap carefully.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions